NCT05869578

Brief Summary

To assess mortality and morbidity associated to anesthesia interventions

Trial Health

63
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
10,000

participants targeted

Target at P75+ for all trials

Timeline
227mo left

Started Jun 2023

Longer than P75 for all trials

Geographic Reach
1 country

1 active site

Status
not yet recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress14%
Jun 2023Jan 2045

First Submitted

Initial submission to the registry

April 27, 2023

Completed
25 days until next milestone

First Posted

Study publicly available on registry

May 22, 2023

Completed
10 days until next milestone

Study Start

First participant enrolled

June 1, 2023

Completed
11.6 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

January 1, 2035

Expected
10 years until next milestone

Study Completion

Last participant's last visit for all outcomes

January 1, 2045

Last Updated

May 22, 2023

Status Verified

May 1, 2023

Enrollment Period

11.6 years

First QC Date

April 27, 2023

Last Update Submit

May 19, 2023

Conditions

Outcome Measures

Primary Outcomes (5)

  • All-cause mortality rate in the postoperative period

    Posoperative mortality of individuals exposed to any anesthesia related intervention or event

    30 days

  • All-cause mortality rate in the posoperative period

    Posoperative mortality of individuals exposed to any anesthesia related intervention or event

    one year

  • Number of patients presenting a complication in the posoperative period

    Perioperative morbidity of individuals exposed to any anesthesia related intervention or event.

    30 days

  • Number of patients who needed rehospitalization in the posoperative period

    Posoperative rehospitalization rate of individuals exposed to any anesthesia related intervention or event, after primary discharge

    7 days after primary discharge

  • Number of deaths in the postoperative period after readmission

    In-hospital mortality of patients that were readmitted after primary discharge

    up to 30 days

Secondary Outcomes (4)

  • Change from baseline in pain, as measured by the visual analog scale (VAS)

    Baseline pre-intervention VAS, postoperative/intervention 1 hour VAS, postoperative/intervention 24 hour VAS

  • Number of patients that develops postoperative acute kidney injury, as measured by Kidney Disease Improving Global Outcomes (KIDGO)-2012 serum creatinine criteria

    7 and 30 days

  • Number of patients that develops postoperative Major Acute Cardiac Events (MACE), as defined by the American Heart Association

    7 and 30 days

  • Number of patients that develop posoperative chronic pain as measured by visual analog scale

    3, 6, and 12 months

Interventions

Patients exposed to any anesthesia intervention will be assessed to whether the exposure to anesthesia confers a risk for perioperative outcomes

Eligibility Criteria

Sexall
Healthy VolunteersYes
Age GroupsChild (0-17), Adult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Individuals of all ages being admitted at Clinica Alemana de Santiago that will require or were in care by an anesthesiologist.

You may qualify if:

  • All individuals
  • Individuals agreeing to participate in the study by signing a consent

You may not qualify if:

  • The subjects who had insufficient data in their files

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Clinica Alemana de Santiago

Santiago, Santiago Metropolitan, 7591538, Chile

Location

Related Publications (5)

  • Abdel-Kader AK, Eisenkraft JB, Katz DJ. Overview and Limitations of Database Research in Anesthesiology: A Narrative Review. Anesth Analg. 2021 Apr 1;132(4):1012-1022. doi: 10.1213/ANE.0000000000005346.

    PMID: 33346984BACKGROUND
  • Kristensen SD, Knuuti J, Saraste A, Anker S, Botker HE, De Hert S, Ford I, Gonzalez Juanatey JR, Gorenek B, Heyndrickx GR, Hoeft A, Huber K, Iung B, Kjeldsen KP, Longrois D, Luescher TF, Pierard L, Pocock S, Price S, Roffi M, Sirnes PA, Uva MS, Voudris V, Funck-Brentano C; Authors/Task Force Members. 2014 ESC/ESA Guidelines on non-cardiac surgery: cardiovascular assessment and management: The Joint Task Force on non-cardiac surgery: cardiovascular assessment and management of the European Society of Cardiology (ESC) and the European Society of Anaesthesiology (ESA). Eur J Anaesthesiol. 2014 Oct;31(10):517-73. doi: 10.1097/EJA.0000000000000150. No abstract available.

    PMID: 25127426BACKGROUND
  • Gupta PK, Gupta H, Sundaram A, Kaushik M, Fang X, Miller WJ, Esterbrooks DJ, Hunter CB, Pipinos II, Johanning JM, Lynch TG, Forse RA, Mohiuddin SM, Mooss AN. Development and validation of a risk calculator for prediction of cardiac risk after surgery. Circulation. 2011 Jul 26;124(4):381-7. doi: 10.1161/CIRCULATIONAHA.110.015701. Epub 2011 Jul 5.

    PMID: 21730309BACKGROUND
  • Fleisher LA, Fleischmann KE, Auerbach AD, Barnason SA, Beckman JA, Bozkurt B, Davila-Roman VG, Gerhard-Herman MD, Holly TA, Kane GC, Marine JE, Nelson MT, Spencer CC, Thompson A, Ting HH, Uretsky BF, Wijeysundera DN. 2014 ACC/AHA guideline on perioperative cardiovascular evaluation and management of patients undergoing noncardiac surgery: executive summary: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. Circulation. 2014 Dec 9;130(24):2215-45. doi: 10.1161/CIR.0000000000000105. Epub 2014 Aug 1. No abstract available.

    PMID: 25085962BACKGROUND
  • Bosco E, Hsueh L, McConeghy KW, Gravenstein S, Saade E. Major adverse cardiovascular event definitions used in observational analysis of administrative databases: a systematic review. BMC Med Res Methodol. 2021 Nov 6;21(1):241. doi: 10.1186/s12874-021-01440-5.

    PMID: 34742250BACKGROUND

MeSH Terms

Conditions

Postoperative Complications

Condition Hierarchy (Ancestors)

Pathologic ProcessesPathological Conditions, Signs and Symptoms

Central Study Contacts

Javiera A Vargas, MD

CONTACT

Patricio A Leyton, MD

CONTACT

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
OTHER
Target Duration
1 Year
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

April 27, 2023

First Posted

May 22, 2023

Study Start

June 1, 2023

Primary Completion (Estimated)

January 1, 2035

Study Completion (Estimated)

January 1, 2045

Last Updated

May 22, 2023

Record last verified: 2023-05

Locations